Study of Safety and Efficacy of Mometasone Furoate Used in Combination With Formoterol Fumarate Compared With Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

Condition:   Asthma
Interventions:   Drug: MK-0887A 100/10 mcg;   Drug: MK-0887 100 mcg;   Drug: Albuterol/Salbutamol;   Drug: Prednisone/Prednisolone
Sponsor:   Merck Sharp & Dohme Corp.
Not yet recruiting – verified April 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Sweden says AstraZeneca used questionable asthma drug API from Indian plant – FiercePharma Manufacturing

Sweden says AstraZeneca used questionable asthma drug API from Indian plant
FiercePharma Manufacturing
AstraZeneca ($AZN) said last week it was closing a plant in India that made the API for asthma drugs, noting there is not much demand any longer for the terbutaline sulfate it makes. But what the U.K. company did not say was that before its closing

View full post on asthma – Google News

FDA grants 501(k) clearance for platform used in association to treat asthma, COPD – Healio


Xconomy

FDA grants 501(k) clearance for platform used in association to treat asthma, COPD
Healio
“501(k) clearance of our platform with inhaler devices from leading global respiratory companies GlaxoSmithKline and Boehringer Ingelheim opens the doors for millions of patients to expect and achieve something better in asthma and COPD,” David Van …
FDA Clears 2 New Propeller Health Devices That Track Respiratory MedsXconomy
Propeller Health Receives FDA Clearance For The Propeller Platform In Pharmaceutical Online (press release)
FDA Approves Propeller Health Mobile Platform for GlaxoSmithKline's Diskus DPI Lung Disease News
FierceMedicalDevices (press release) (registration)
all 18 news articles »

View full post on asthma – Google News